Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of Utah
Salt Lake City, Utah
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 646. We're showing you the first 500 records. If you need every record from this institution, you can download all of our data at the ProPublica Data Store.
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Howard Colman | Conflict of Interest | Hoffman La Roche/Genetech | $5,000-9,999 | 2012-2019 |
| Feng Liu | Conflict of Interest | LIFE-E | $5,000-9,999 | 2012-2019 |
| Douglas Sborov | Conflict of Interest | Celgene | $5,000-9,999 | 2012-2019 |
| Howard Colman | Conflict of Interest | Hoffman La Roche/Genetech | $5,000-9,999 | 2012-2019 |
| Christopher Pelt | Conflict of Interest | Biomet | $5,000-9,999 | 2012-2019 |
| Douglas Sborov | Conflict of Interest | Celgene | $5,000-9,999 | 2012-2019 |
| Karen Eilbeck | Conflict of Interest | IDbyDNA | $5,000-9,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $5,000-9,999 | 2012-2019 |
| Mark Yandell | Conflict of Interest | IDbyDNA | $5,000-9,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $5,000-9,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Pfizer | $5,000-9,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $5,000-9,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Bristol-Myers Squibb | $5,000-9,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Pfizer | $5,000-9,999 | 2012-2019 |
| Leslie Jerominski | Conflict of Interest | Janssen Pharmaceutical Inc | $5,000-9,999 | 2012-2019 |
| Douglas Sborov | Conflict of Interest | Celgene | $5,000-9,999 | 2012-2019 |
| Howard Colman | Conflict of Interest | Hoffman La Roche | $5,000-9,999 | 2012-2019 |
| Harry Hill | Conflict of Interest | Vidara Therapeutics | $5,000-9,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $5,000 - $9,999 | 2016 |
| Peter Stevens | Conflict of Interest | Orthopediatrics, Inc. | $5,000-9,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Amgen/Onyx | $5,000-9,999 | 2012-2019 |
| Gerald Gleich | Conflict of Interest | GlaxoSmithKline | $5,000-9,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $5,000-9,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $5,000-9,999 | 2012-2019 |
| Gerald Gleich | Conflict of Interest | GlaxoSmithKline | $5,000-9,999 | 2012-2019 |
| Carrie Byington | Conflict of Interest | N/A | $5,000-9,999 | 2012-2019 |
| Roger Freedman | Conflict of Interest | Medtronic | $5,000-9,999 | 2012-2019 |
| Roger Freedman | Conflict of Interest | Medtronic | $5,000-9,999 | 2012-2019 |
| Jeremy Gililland | Conflict of Interest | Smith & Nephew | $5,000-9,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $5,000-9,999 | 2012-2019 |
| Gerald Gleich | Conflict of Interest | GlaxoSmithKline | $5,000-9,999 | 2012-2019 |
| Gerald Gleich | Conflict of Interest | GlaxoSmithKline | $5,000-9,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Incyte | $5,000-9,999 | 2012-2019 |
| Carrie Byington | Conflict of Interest | N/A | $5,000-9,999 | 2012-2019 |
| Gerald Gleich | Conflict of Interest | GlaxoSmithKline | $5,000-9,999 | 2012-2019 |
| Carrie Byington | Conflict of Interest | N/A | $5,000-9,999 | 2012-2019 |
| Howard Colman | Conflict of Interest | Hoffman La Roche/Genetech | $5,000-9,999 | 2012-2019 |
| Gerald Gleich | Conflict of Interest | GlaxoSmithKline | $5,000-9,999 | 2012-2019 |
| Christopher Pelt | Conflict of Interest | Biomet | $5,000-9,999 | 2012-2019 |
| Terry Box | Conflict of Interest | Gilead | $5,000-9,999 | 2012-2019 |
| Paul Bernstein | Conflict of Interest | Spark Therapeutics | $5,000-9,999 | 2012-2019 |
| Bruce Gale | Conflict of Interest | NanoNC | $5,000-9,999 | 2012-2019 |
| Paul Bernstein | Conflict of Interest | Spark Therapeutics | $5,000-9,999 | 2012-2019 |
| Swomitra Mohanty | Conflict of Interest | Nanosynth Materials and Sensors Inc | $5,000-9,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Bristol-Myers Squibb | $5,000-9,999 | 2012-2019 |
| Irene De | Conflict of Interest | Alexion | $5,000-9,999 | 2012-2019 |
| Michael Riley | Conflict of Interest | NOLS | $5,000-9,999 | 2012-2019 |
| Jeremy Gililland | Conflict of Interest | OrthoGrid Technologies | $5,000-9,999 | 2012-2019 |
| Joel Cooper | Conflict of Interest | Red Scientific | $5,000-9,999 | 2012-2019 |
| Howard Colman | Conflict of Interest | Hoffman La Roche/Genetech | $5,000-9,999 | 2012-2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.